Back

Impact of new definition on the prognosis of patients with pulmonary hypertension compared to classic definition

2 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Current pharmacological treatments for pulmonary hypertension Diagnostic Methods ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor So-Young Lee

Seoul St. Marys Hospital, Seoul (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
Effects of beta blockers on outcome in patients with PAH with and without comorbid conditions: a Multicenter Prospective Cohort Study (BNP-PL).
Doctor M. Waligora (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Combined ARNI and SGLT2i impacts on peak tricuspid regurgitant velocity and echocardiographic probability of pulmonary hypertension
Doctor M. Stracqualursi (Milan, IT)
Abstract Slides Video
Presentation thumbnail
The safety and efficacy of treprostinil for the treatment of pulmonary arterial hypertension: a systematic review and meta-analysis of randomized controlled trials
Mr H. Khasawneh (Irbid, JO)
Abstract Slides Video
Presentation thumbnail
Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension : insights from a single-centre study
Doctor H. Tokgoz (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Metoprolol therapy in patients with Eisenmenger syndrome (MINES) study. A single-centre, double-blinded, randomised, placebo-controlled trial
Doctor A. Pius (New Delhi, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Current pharmacological treatments for pulmonary hypertension

The Event

Event poster

ESC Congress 2024

2 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of new definition on the prognosis of patients with pulmonary hypertension compared to classic definition
thumbnail
Congress Presentation
Impact of latest 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: retrospective single center cohort study
thumbnail
Congress Presentation
Impact of the 2022 ESC/ERS guidelines on diagnosing pulmonary hypertension in heart failure with reduced ejection fraction patients undergoing elective right heart catheterization

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources